| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $469K | -32.2% |
| SG&A Expense | $1.1M | +2.0% |
| Operating Income | -$6.5M | -47.0% |
| Interest Expense | $0 | -100.0% |
| Income Tax | $0 | — |
| Net Income | -$4.3M | -1.8% |
| EPS (Basic) | -$0.22 | +18.5% |
| EPS (Diluted) | -$0.22 |
| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.0M | -20.3% |
| Current Assets | $68.1M | -20.3% |
| Total Assets | $73.3M | -19.1% |
| Current Liabilities | $587K | -16.7% |
| Total Liabilities | $587K | -16.7% |
| Stockholders' Equity | $72.7M | -19.2% |
| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.8M | +7.9% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | -$13.6M | -115.5% |